A retrospective analysis presented at the American Society of Clinical Oncology 2025 Annual Meeting suggests that higher tumor mutational burden (TMB) may be linked to longer progression-free survival in...
The latest OVATION-2 trial update, presented at the American Society of Clinical Oncology 2025 annual meeting, shows that adding intraperitoneal IMNN-001 to standard neoadjuvant chemotherapy improved both...
A phase II trial evaluating pembrolizumab plus lenvatinib in clear cell ovarian carcinoma shows promising response rates and 6-month progression-free survival.
A retrospective analysis from Memorial Sloan Kettering links higher patient-reported pain to increased emergency department utilization among individuals newly diagnosed with ovarian cancer. This study was...
A pilot study from the University of Pennsylvania has found that a simple electronic nudge embedded in the electronic health record increased referrals to gynecologic oncology for patients with suspected...
Researchers developed a population-based cohort study to determine whether there are associations between endometriosis subtypes and incidence of ovarian cancer.
A recent ancillary analysis of the LANCE trial examined the feasibility and perioperative outcomes of hyperthermic intraperitoneal chemotherapy in patients undergoing minimally invasive surgery compared...
A recent retrospective cohort study assessed the prevalence of germline and somatic mutations in patients with ovarian carcinosarcoma and their impact on cancer-related outcomes, highlighting the need for...
A retrospective analysis of the National Cancer Database suggests that incorporating laparoscopy before laparotomy in primary debulking surgery improves overall survival in stage IIIC epithelial ovarian...
